beta-adrenoreceptor blocking heterocyclic oximes and ethers

被引:0
|
作者
Manna, F
Chimenti, F
Bolasco, A
Lena, R
Filippelli, A
Falciani, M
Fontana, M
机构
[1] UNIV REGGIO CALABRIA,FAC FARM,REGGIO CALABRIA,ITALY
[2] UNIV NAPLES 2,FAC MED & CHIRURG,IST FARMACOL & TOSSICOL,NAPLES,ITALY
[3] UNIV ROMA LA SAPIENZA,DIPARTIMENTO SCI BIOCHIM,I-00185 ROME,ITALY
来源
FARMACO | 1996年 / 51卷 / 11期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper reports synthesis and pharmacological properties of thienyl, pyrrol, indolyl and benzofuryl-O-(3-alkylamine-2-hydroxypropyl)oximes and some 3-(3-alkylamine-2-hydroxypropyl)alkyloxy indoles aiming to study the influence of five membered and condensed heterocyclic substituents on the beta-adrenoreceptor inhibiting potency. All heterocyclic derivatives synthesized (1-17) were less active than the reference propranolol on the rat heart, while showed a comparable potency on the guinea pig trachea, exibiting a significant beta(2)-selectivity. The low beta-blocking potency of the five membered derivatives seemed to confirm the negative influence of the polarization of the oximic carbon in the binding with non polar region of the beta-adrenoreceptor. Another important interaction could take place with the enzime adenyl-cyclase which is responsible of the signal of transduction. It could be hypothesized that the heteroatom of the heterocyclic nucleus acted as an electron-donor group and engaged a cohordinative bond with magnesium atom present on the adenylcyclase system; responsible of the agonist activity. The pharmacological in vivo experiments and the binding results were in accordance with the in vitro data.
引用
收藏
页码:699 / 706
页数:8
相关论文
共 50 条
  • [31] THE BETA-ADRENORECEPTOR IN HUMAN-LYMPHOCYTES
    WATANABE, Y
    LAI, RT
    YOSHIDA, H
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1981, 8 (03) : 273 - 276
  • [32] METABOLIC EFFECTS OF BETA-ADRENORECEPTOR BLOCKERS
    WAALMANNING, HJ
    DRUGS, 1976, 11 : 121 - 126
  • [33] BETA-ADRENORECEPTOR BLOCKADE IN THE TREATMENT OF HYPERTENSION
    SLAVIN, MJ
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 1981, 80 (10): : 684 - 689
  • [34] BETA-ADRENORECEPTOR ANTAGONISTS IN ESSENTIAL TREMOR
    JEFFERSON, D
    JENNER, P
    MARSDEN, CD
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1979, 42 (10): : 904 - 909
  • [35] ROLE OF CARDIAC FACTORS IN THE INITIAL HYPOTENSIVE ACTION BY BETA-ADRENORECEPTOR BLOCKING-AGENTS
    COLFER, HT
    COTTIER, C
    SANCHEZ, R
    JULIUS, S
    HYPERTENSION, 1984, 6 (02) : 145 - 151
  • [36] Gut hormone GPCRs as potential off-targets for beta-adrenoreceptor blocking agents
    Latek, D.
    Pasznik, P.
    Rutkowska, E.
    Niewieczerzal, S.
    Cielecka-Piontek, J.
    Filipek, S.
    FEBS OPEN BIO, 2018, 8 : 347 - 348
  • [37] LIVER-TUMORS INDUCED BY A NEW BETA-ADRENORECEPTOR BLOCKING-AGENT IN FEMALE RATS
    RAGNOTTI, G
    PRESTA, M
    RIBONI, L
    ZAVANELLA, T
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1982, 68 (04) : 669 - 672
  • [38] BETA-ADRENORECEPTOR BLOCKING-DRUGS AND THYROID-HORMONES IN HYPER-THYROID SUBJECTS
    JONES, MK
    OWENS, DR
    BIRTWELL, J
    JONES, GR
    LEWIS, M
    POSTGRADUATE MEDICAL JOURNAL, 1981, 57 (666) : 207 - 209
  • [39] The acute effect of topical beta-adrenoreceptor blocking agents on retinal and optic nerve head circulation
    Arend, O
    Harris, A
    Arend, S
    Remky, A
    Martin, BJ
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 1998, 76 (01): : 43 - 49
  • [40] Beta-adrenoreceptor agonists for diffuse esophageal spasm
    Okamura, S
    Oshimoto, H
    Sakamoto, T
    Kusano, M
    Sekiguchi, T
    Mori, M
    JOURNAL OF GASTROENTEROLOGY, 2002, 37 (03) : 229 - 230